Porter-Steele Janine P, Sharples Katrina J, Laing Bobbi B, Benge Sarah, Balaam Sarah M, Vear Natalie K, Findlay Michael P N, Campbell Ian D, Kuper-Hommel Marion J J, Anderson Debra J, Porter David J, McCarthy Alexandra L
Griffith Health Group Executive, Griffith University, Gold Coast Campus, Southport, Australia.
School of Nursing, Midwifery and Social Work, The University of Queensland, Level 3, Chamberlain Building (35), St Lucia, Brisbane, QLD, 4072, Australia.
Support Care Cancer. 2025 Jun 5;33(7):546. doi: 10.1007/s00520-025-09601-8.
This paper reports the feasibility testing of the Younger Women's Wellness after Cancer Program in Aotearoa New Zealand (the 'Kōwhai Study') by examining (a) intervention uptake, adherence, and sustainability over time and (b) the feasibility of the proposed trial methods.
Participants were female, aged between 18 and 50 years, and had completed stage I or II breast cancer treatment within the previous 24 months. They also had internet access. Participants were randomly allocated 1:1 to the intervention or control group. The intervention consisted of systematic 12-week internet-based individualised coaching based on promoting a sustainable healthy lifestyle and managing treatment side effects. The control group received the usual care expected from their treating healthcare teams. Outcomes were measured at baseline, week 12, and week 24. The sample size for the study was 60 participants.
Target N = 60 was reached, with groups evenly matched socio-demographically. All participants completed all questionnaires at baseline (average 15-20 min to complete). Complete intervention/control questionnaire data was provided at week 12 by 76.7%/73.3% and week 24 by 86.7%/70.0% respectively. The 12-week intervention was completed by 28/30 participants. Free-text data strongly indicated intervention and study processes were acceptable and feasible to participants.
In Aotearoa New Zealand, the intervention is valued by the target group and the study processes are feasible. Trial registration Australian New Zealand Clinical Trials Registry, ACTRN12620000260921. Registered on 27 February 2020.
本文通过考察(a)随着时间推移干预措施的采用、依从性和可持续性,以及(b)所提议试验方法的可行性,报告了新西兰奥特亚罗瓦地区开展的“癌症后年轻女性健康计划”(“科怀研究”)的可行性测试。
参与者为年龄在18至50岁之间的女性,且在过去24个月内完成了I期或II期乳腺癌治疗。她们还具备网络接入条件。参与者按1:1随机分配至干预组或对照组。干预措施包括基于促进可持续健康生活方式和管理治疗副作用的为期12周的系统性在线个性化辅导。对照组接受其治疗医疗团队提供的常规护理。在基线、第12周和第24周对结果进行测量。该研究的样本量为60名参与者。
达到了目标样本量N = 60,两组在社会人口统计学特征上均衡匹配。所有参与者均在基线时完成了所有问卷(平均完成时间为15 - 20分钟)。在第12周时,分别有76.7%/73.3%的干预组/对照组参与者提供了完整的问卷数据;在第24周时,这一比例分别为86.7%/70.0%。30名干预组参与者中有28名完成了为期12周的干预。自由文本数据有力地表明,干预措施和研究流程为参与者所接受且可行。
在新西兰奥特亚罗瓦地区,该干预措施受到目标群体重视,研究流程可行。试验注册澳大利亚新西兰临床试验注册中心,ACTRN12620000260921。于2020年2月27日注册。